Clinical Trial Update: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Patients With Active Illicit Substance usE [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1-infected patients with active illicit substance use; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)

Snippet

Sponsor: University of Nebraska | Conditions: HIV-1-infection | Phase 4 | Status: COMPLETED | Results posted: 2022-12-20